Abstract:Missense mutations of human fibroblast growth factor receptor 3 (FGFR3) result in several skeletal dysplasias, including hypochondroplasia, achondroplasia and thanatophoric dysplasia. To study the function of FGFR3 in bone growth and to create animal models for the FGFR3-related inherited skeletal disorders, we introduced a point mutation (Lys644Glu) into the murine FGFR3 genome using a knock-in approach. We found that the Lys644Glu mutation resulted in retarded endochondral bone growth with severity directly linked to the expression level of the mutated Fgfr3. Mice heterozygous for the mutation ( Fgfr3(TD/+) ) expressed the mutant allele at approximately 20% of the wild-type level and exhibited a mild bone dysplasia. However, when the copy number of the mutant allele increased from one (Fgfr3(TD/+) to two (Fgfr3(TD/TD), the retardation of bone growth became more severe and showed phenotypes resembling those of achondroplasia patients, characterized by a dramatically reduced proliferation of growth plate cartilage, macrocephaly and shortening of the long bones, which was most pronounced in the femur. Molecular analysis revealed that expression of the mutant receptor caused the activation of Stat1, Stat5a and Stat5b, and the up-regulation of p16, p18 and p19 cell cycle inhibitors, leading to dramatic expansion of the resting zone of chondrocytes at the expense of the proliferating chondrocytes. The mutant growth plates consequently were in a less active state and generated fewer maturing and hypertrophic chondrocytes. These data provide direct genetic evidence that the point mutations in FGFR3 cause human skeletal dysplasias and uncover a mechanism through which the FGFR3 signals regulate bone growth by modulating expression of Stats and ink4 cell cycle inhibitors.

Motor deficits in fibroblast growth factor receptor-3 null mutant mice.

A Neonatal Lethal Mutation in FGFR3 Uncouples Proliferation and Differentiation of Growth Plate Chondrocytes in Embryos.

A Lys644Glu Substitution in Fibroblast Growth Factor Receptor 3 (FGFR3) Causes Dwarfism in Mice by Activation of STATs and Ink4 Cell Cycle Inhibitors.

Mouse Models Orthologous to FGFR3-related Skeletal Dysplasias.

FGFR3 Induces Degradation of BMP Type I Receptor to Regulate Skeletal Development.

[Gly374arg Mutation in Fgfr3 Causes Achondroplasia in Mice].

Gly369Cys Mutation in Mouse FGFR3 Causes Achondroplasia by Affecting Both Chondrogenesis and Osteogenesis.

Fibroblast Growth-Factor Receptor-3 Is A Negative Regulator Of Bone-Growth And Development

Generation of Fgfr3 Conditional Knockout Mice

FGFR3 deficient mice have accelerated fracture repair

A Ser(365)-->Cys Mutation of Fibroblast Growth Factor Receptor 3 in Mouse Downregulates Ihh/PTHrP Signals and Causes Severe Achondroplasia.

Molecular therapeutic strategies for FGFR3 gene-related skeletal dysplasia

A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.

Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice

Highly Activated Fgfr3 with the K644M Mutation Causes Prolonged Survival in Severe Dwarf Mice

Defective Lysosomal Targeting of Activated Fibroblast Growth Factor Receptor 3 in Achondroplasia.

Mouse genetics identifies unique and overlapping functions of fibroblast growth factor receptors in keratinocytes

Impairment of Spatial Learning and Memory in Transgenic Mice Overexpressing Human Fibroblast Growth Factor-23

Fibroblast Growth Factor Receptor-1 (Fgfr-1) Is Essential For Normal Neural Tube And Limb Development

FGFR3 Deficiency Enhances CXCL12-dependent Chemotaxis of Macrophages Via Upregulating CXCR7 and Aggravates Joint Destruction in Mice.

Celsr3 Inactivation in the Brainstem Impairs Rubrospinal Tract Development and Mouse Behaviors in Motor Coordination and Mechanic-Induced Response